Federal Minister of Health Spahn expects the first delivery of the newly approved vaccine from the manufacturer Johnson & Johnson in mid-April.
In a discussion with citizens on the Internet, Spahn said that it was initially about 275,000 doses of the preparation. He emphasized that with this vaccine, one dose is already sufficient for immunization. In principle, all approved vaccines would be used for vaccination in general practitioners’ practices, but due to availability, first the preparation from Biontech / Pfizer, and later also that from Astrazeneca. The Moderna vaccine will initially be used primarily in vaccination centers. Above all, professional groups with high priority would be immunized there. Existing dates remained valid.
The President of the Paul Ehrlich Institute, Cichutek, pointed out that another three vaccines are in an advanced phase of testing for approval by the European Medicines Agency. These are the preparations from Curevac, Novavax and the Russian vaccine Sputnik V.
This message was broadcast on March 27th, 2021 on Deutschlandfunk.